Systemic inflammation in NAFLD is associated with an elevated level of CCL2 in serum samples in addition to increases in IL-6 and CCL19 but not C-reactive protein (CRP) [93]. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.